Zhuhai Trinomab Pharmaceutical Co (SHSE:688806) Buyback Yield %: 0.00 (As of Sep. 10, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

SHSE:688806 Zhuhai Trinomab Pharmaceutical Co Ltd SHSE:688806
2 GF Score
Price ¥20.72
! 7 Warning Signs
View Full Analysis

What is Zhuhai Trinomab Pharmaceutical Co Buyback Yield %?

Zhuhai Trinomab Pharmaceutical Co SHSE:688806 -4.38% 2 Buyback Yield % is 0.00 as of Sep. 10, 2026. GuruFocus rates SHSE:688806 with a GF Score™ of 2/100. The stock has 7 warning signs investors should review. Among 235 Drug Manufacturers companies, Zhuhai Trinomab Pharmaceutical Co ranks worse than 425531.49% on this metric.

Buyback yield is the net repurchase of shares outstanding over the market capital of the company. It is a measure of shareholder return.

Zhuhai Trinomab Pharmaceutical Co's current buyback yield was 0.00%.

Zhuhai Trinomab Pharmaceutical Co Buyback Yield % Related Terms

Zhuhai Trinomab Pharmaceutical Co Buyback Yield % Historical Data

* Premium members only.

The historical data trend for Zhuhai Trinomab Pharmaceutical Co's Buyback Yield % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Zhuhai Trinomab Pharmaceutical Co Buyback Yield % Chart

Zhuhai Trinomab Pharmaceutical Co Annual Data
Trend Dec22 Dec23 Dec24 Dec25
Buyback Yield %
0.00 0.00 0.00 0.00

Zhuhai Trinomab Pharmaceutical Co Semi-Annual Data
Dec22 Dec23 Dec24 Dec25
Buyback Yield % 0.00 0.00 0.00 0.00

SHSE:688806 vs ZTS: Buyback Yield % Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Zhuhai Trinomab Pharmaceutical Co's Buyback Yield %, along with its competitors' market caps and Buyback Yield % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Zhuhai Trinomab Pharmaceutical Co Buyback Yield % vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Zhuhai Trinomab Pharmaceutical Co's Buyback Yield % distribution charts can be found below:

* The bar in red indicates where Zhuhai Trinomab Pharmaceutical Co's Buyback Yield % falls into.


SHSE:688806
2GF Score
Zhuhai Trinomab Pharmaceutical Co Ltd SHSE:688806
Buyback Yield % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Zhuhai Trinomab Pharmaceutical Co Buyback Yield % Calculation

Buyback yield is a measure of shareholder return.

Zhuhai Trinomab Pharmaceutical Co's Buyback Yield for the fiscal year that ended in Dec. 2025 is calculated as

Buyback Yield=Net Issuance of Stock / Market Cap
=- (Repurchase of Stock + Issuance of Stock) / Market Cap
=- (0 + 0) / 0
=N/A%

Zhuhai Trinomab Pharmaceutical Co's annualized Buyback Yield for the quarter that ended in Dec. 2025 is calculated as

Buyback Yield=Net Issuance of Stock(TTM) / Market Cap
=- (Repurchase of Stock + Issuance of Stock) (TTM)** / Market Cap
=- (0 + 0) / 0
=N/A%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

** If the quarter corresponds to the year-end period, we will use the annual Repurchase of Stock and Issuance of Stock data .

Frequently Asked Questions Learn more about Buyback Yield % →
What does a Buyback Yield % of 0.00 mean?
Zhuhai Trinomab Pharmaceutical Co (SHSE:688806) has a Buyback Yield % of 0.00 as of Sep. 10, 2026. Share buyback yield equals the net issuance of stock divided by market cap. View historical data on Zhuhai Trinomab Pharmaceutical Co and its competitors. According to the industry distribution chart, Zhuhai Trinomab Pharmaceutical Co ranks #999999 out of 235 companies in the Drug Manufacturers industry.
Is Zhuhai Trinomab Pharmaceutical Co's Buyback Yield % too high?
Zhuhai Trinomab Pharmaceutical Co's current Buyback Yield % is 0.00. Based on the distribution chart, Zhuhai Trinomab Pharmaceutical Co ranks #999999 out of 235 companies in the Drug Manufacturers industry, which is in the bottom quartile relative to peers. Overall, Zhuhai Trinomab Pharmaceutical Co has a GF Score™ of 2/100, reflecting its overall financial health beyond just this single metric.
How does Zhuhai Trinomab Pharmaceutical Co's Buyback Yield % compare to ZTS?
According to the Drug Manufacturers industry distribution chart, Zhuhai Trinomab Pharmaceutical Co ranks #999999 out of 235 companies for Buyback Yield %. This places Zhuhai Trinomab Pharmaceutical Co in the lower half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Buyback Yield % for a Drug Manufacturers company?
A good Buyback Yield % depends on the Drug Manufacturers industry context. However, Buyback Yield % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Buyback Yield % mean?
A high Buyback Yield % can signal that a stock is expensive relative to its fundamentals. Share buyback yield equals the net issuance of stock divided by market cap. View historical data on Zhuhai Trinomab Pharmaceutical Co and its competitors. Zhuhai Trinomab Pharmaceutical Co's current Buyback Yield % is 0.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Zhuhai Trinomab Pharmaceutical Co stock overvalued right now?
Zhuhai Trinomab Pharmaceutical Co (SHSE:688806) has a current Buyback Yield % of 0.00. The current Buyback Yield % is 0.00. Zhuhai Trinomab Pharmaceutical Co's overall GF Score™ is 2/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Buyback Yield % calculated?
Buyback Yield % is calculated from a company's financial statements. For Zhuhai Trinomab Pharmaceutical Co (SHSE:688806), the current Buyback Yield % is 0.00 as of Sep. 10, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
2GF Score

Get the complete analysis for SHSE:688806

Buyback Yield % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

¥20.72
Price